Vistagen adopts new Executive Severance Plan
Vistagen Therapeutics, Inc. adopted an Executive Severance Plan effective October 7, 2026, to provide key employees with severance payments and other benefits upon resignation or termination without cause, amending the previous Change in Control Executive Severance Plan. This establishes the terms for retention following an involuntary termination.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed